Presagen has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF.
The new capital will further strengthen the partnership as the addition of biometric information such as blood pressure from Omron's precision wearable devices will maximize the utility of Genesis' genetic data-sharing platform.